Comerica Bank Regeneron Pharmaceuticals, Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Comerica Bank holds 15,551 shares of REGN stock, worth $11.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

15,551

Previous 15,360 1.24%

Holding current value

$11.5 Million

Previous $16.1 Million 1.26%

% of portfolio

0.07%

Previous 0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $195,601 - $229,536	191 Added 1.24%	15,551 $16.3 Million
Q2 2024 Aug 15, 2024	BUY	$883.2 - $1071.19 $47,692 - $57,844	54 Added 0.35%	15,360 $16.1 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $327,676 - $360,586	-363 Reduced 2.32%	15,306 $14.7 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $493,789 - $561,642	-637 Reduced 3.91%	15,669 $13.8 Million
Q3 2023 Nov 21, 2023	SELL	$692.45 - $844.37 $4.06 Million - $4.95 Million	-5,863 Reduced 26.45%	16,306 $13.4 Million
Q2 2023 Aug 22, 2023	BUY	$700.03 - $830.35 $5.92 Million - $7.02 Million	8,451 Added 61.61%	22,169 $1,000
Q4 2022 Jan 26, 2023	SELL	$705.89 - $766.39 $301,415 - $327,248	-427 Reduced 3.02%	13,718 $0
Q3 2022 Oct 28, 2022	SELL	$573.97 - $724.32 $134,882 - $170,215	-235 Reduced 1.63%	14,145 $10.4 Million
Q2 2022 Aug 02, 2022	BUY	$548.35 - $738.84 $91,574 - $123,386	167 Added 1.17%	14,380 $8.57 Million
Q1 2022 Apr 27, 2022	SELL	$595.12 - $698.43 $185,677 - $217,910	-312 Reduced 2.15%	14,213 $9.93 Million
Q4 2021 Feb 18, 2022	SELL	$543.48 - $670.97 $115,217 - $142,245	-212 Reduced 1.44%	14,525 $9.17 Million
Q3 2021 Nov 22, 2021	SELL	$574.03 - $680.96 $2.45 Million - $2.91 Million	-4,276 Reduced 22.49%	14,737 $8.92 Million
Q2 2021 Aug 26, 2021	SELL	$472.8 - $558.54 $556,958 - $657,960	-1,178 Reduced 5.83%	19,013 $10.6 Million
Q1 2021 Apr 28, 2021	SELL	$446.73 - $548.2 $168,863 - $207,219	-378 Reduced 1.84%	20,191 $9.55 Million
Q4 2020 Jan 28, 2021	BUY	$478.3 - $607.98 $466,342 - $592,780	975 Added 4.98%	20,569 $9.94 Million
Q3 2020 Oct 30, 2020	BUY	$544.75 - $658.21 $497,356 - $600,945	913 Added 4.89%	19,594 $11 Million
Q2 2020 Jul 31, 2020	BUY	$493.32 - $643.92 $1.72 Million - $2.24 Million	3,483 Added 22.92%	18,681 $11.7 Million
Q1 2020 May 01, 2020	SELL	$336.18 - $494.43 $130,101 - $191,344	-387 Reduced 2.48%	15,198 $7.42 Million
Q4 2019 Feb 07, 2020	SELL	$274.13 - $376.51 $80,868 - $111,070	-295 Reduced 1.86%	15,585 $5.85 Million
Q3 2019 Oct 31, 2019	BUY	$273.46 - $318.39 $201,266 - $234,335	736 Added 4.86%	15,880 $4.41 Million
Q2 2019 Aug 02, 2019	SELL	$299.6 - $414.82 $35,053 - $48,533	-117 Reduced 0.77%	15,144 $0
Q1 2019 May 02, 2019	SELL	$372.08 - $439.57 $5.46 Million - $6.46 Million	-14,685 Reduced 49.04%	15,261 $0
Q4 2018 Feb 06, 2019	SELL	$335.82 - $403.04 $1.81 Million - $2.17 Million	-5,379 Reduced 15.23%	29,946 $12.5 Million
Q3 2018 Nov 01, 2018	SELL	$351.14 - $408.51 $1.54 Million - $1.79 Million	-4,391 Reduced 11.06%	35,325 $13.4 Million
Q2 2018 Aug 01, 2018	BUY	$284.6 - $344.99 $6,830 - $8,279	24 Added 0.06%	39,716 $14.5 Million
Q1 2018 May 01, 2018	BUY	$315.82 - $393.78 $890,296 - $1.11 Million	2,819 Added 7.65%	39,692 $12.5 Million
Q4 2017 Feb 02, 2018	BUY	$358.63 - $469.95 $1.98 Million - $2.59 Million	5,518 Added 17.6%	36,873 $14.1 Million
Q3 2017 Nov 06, 2017	BUY	$431.38 - $504.0 $13.5 Million - $15.8 Million	31,355	31,355 $12.7 Million

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account